|
| Status |
Public on May 01, 2013 |
| Title |
Genetic profiling to predict recurrence of early cervical cancer |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
We compared the prediction powers for disease recurrence between gene set prognostic model and clinical prognostic model developed in a single large population to see whether genetic quantitative approach will have significant prognostic role in early cervical cancer patients who underwent radical hysterectomy with or without adjuvant therapies.
Gene set model to predict disease free survival of early cervical cancer was developed using DASL assay dataset from the cohort of early cervical cancer patients who were treated with radical surgery with or without adjuvant therapies at the Samsung Medical Center of Sungkyunkwan University School of Medicine in Seoul, Korea, between January 2002 and September 2008. Clinical prediction model was also developed in the same cohort and the ability of predicting recurrence from each model was compared.
|
| |
|
| Overall design |
Adequate DASL assay profiles were obtained in 300 patients and we selected 12 genes for the gene set model. When the proportions of patients were categorized as having a low or high risk by the prognostic scores using these genes from LOOCV procedure, the Kaplan-Meier curve showed significant different recurrence rate between two groups. Clinical model was developed using FIGO stage as well as post-surgical pathological findings.
|
| |
|
| Citation(s) |
24145113 |
| Submission date |
Feb 01, 2013 |
| Last update date |
Dec 22, 2017 |
| Contact name |
Yuyoung Lee |
| E-mail(s) |
yyl.lee@samsung.com
|
| Phone |
82-16-501-7392
|
| Organization name |
SMC
|
| Street address |
50 Irwon-Dong, Gangnam-Gu
|
| City |
Seoul |
| ZIP/Postal code |
135710 |
| Country |
South Korea |
| |
|
| Platforms (1) |
| GPL14951 |
Illumina HumanHT-12 WG-DASL V4.0 R2 expression beadchip |
|
| Samples (300)
|
|
| Relations |
| BioProject |
PRJNA188552 |
Less...
More...